voriconazole has been researched along with Meningitis, Cryptococcal in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (31.03) | 29.6817 |
2010's | 16 (55.17) | 24.3611 |
2020's | 4 (13.79) | 2.80 |
Authors | Studies |
---|---|
Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF | 1 |
Fang, T; Jiang, Y; Li, WP; Lin, Q; Peng, FH; Su, XH; Zheng, XJ | 1 |
Jiang, Y; Li, M; Liu, J; Peng, F; Su, X; Wang, A; Wang, Y; Xu, X; Yang, L | 1 |
Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G | 1 |
Guan, Y; Song, QL | 1 |
Aquino, VR; de Azevedo, MI; Goldani, LZ; Neto, GW; Pilla, C; Wirth, F | 1 |
Fica, A; Leiva Hernández, M; Salgueiro C, C; Téllez R, M | 1 |
Gao, T; Huang, XS; Tian, CL; Xing, XW; Yan, B; Yao, Y; Yu, SY; Zhang, JT | 1 |
Animalu, C; Cleveland, KO; Gelfand, MS; Mazumder, S | 1 |
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
Li, SS; Lu, MQ; Ni, SL; Tang, XY; Yang, NB; Zhang, SG | 1 |
Cervera, C; Crespo, G; Marco, F; Michelena, J; Moreno, A; Navasa, M | 1 |
dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I | 1 |
Guggemos, W; Hecht, A; Rüdisser, K; Seilmaier, M | 1 |
Bandettini, R; Calvillo, M; Castagnola, E; Conte, M; Cuzzubbo, D; Faraci, M; Lanino, E; Manzitti, C; Miano, M; Micalizzi, C; Morreale, G; Pescetto, L; Ravegnani, M; Ricagni, L; Soro, O | 1 |
Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P | 1 |
Chang, CM; Chang, HH; Ko, WC; Lee, HC; Lee, NY; Wu, CJ; Yang, YH | 1 |
Atienzar, M; Blanch, JJ; Escribano, E; Rodríguez, M | 1 |
Hogan, BK; Lewis, JS; Nierenberg, NE; Patterson, TF; Thompson, GR | 1 |
Fujishima, K; Fukae, J; Furuya, T; Hattori, N; Hirayama, T; Noda, K; Ogaki, K; Okuma, Y | 1 |
Yong, L | 1 |
Capilla, J; Gazzoni, AF; Guarro, J; Mayayo, E | 1 |
Niki, Y; Ohbayashi, H; Shoji, H; Takuma, T; Yamamoto, T; Yoshida, K | 1 |
Harada, H; Inoue, A; Iwata, S; Kumon, Y; Ohnishi, T; Teraoka, M; Yamashita, D | 1 |
Gamaletsou, MN; Kontos, AN; Kontoyiannis, DP; Kordossis, T; Sipsas, NV; Stefanou, I; Tsiakalos, A | 1 |
Baršić, B; Mlinarić Missoni, E | 1 |
Chiodo, F; Consales, A; Manfredi, R; Pavoni, M; Sabbatani, S | 1 |
Lu, HZ; Shen, YZ; Wang, JR | 1 |
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
29 other study(ies) available for voriconazole and Meningitis, Cryptococcal
Article | Year |
---|---|
New guinea pig model of Cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Guinea Pigs; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2007 |
Case report: a special case of cryptococcal infection-related inflammatory syndrome in a non-HIV infected and non-transplant patient.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Syndrome; Voriconazole | 2022 |
Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Hypokalemia; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome; Voriconazole | 2022 |
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole | 2022 |
A case of acute pancreatitis induced by voriconazole during treatment of cryptococcal meningitis.
Topics: Acute Disease; Adolescent; Child; Female; Humans; Meningitis, Cryptococcal; Pancreas; Pancreatitis; Voriconazole | 2022 |
Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Child; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Pressure; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Treatment Outcome; Voriconazole | 2018 |
[Cerebral cryptococcosis and immune reconstitution inflammatory syndrome. Case report].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Meningitis, Cryptococcal; Middle Aged; Voriconazole | 2018 |
Voriconazole: a novel treatment option for cryptococcal meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Carbon; China; Cryptococcus neoformans; Diagnostic Errors; Drug Therapy, Combination; Female; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers; Time Factors; Voriconazole | 2015 |
Cryptococcus uniguttulatus Meningitis.
Topics: Administration, Intravenous; Aged; Amphotericin B; Antifungal Agents; Cryptococcus; Drug Substitution; Female; Fluconazole; Glucocorticoids; Humans; Immunocompromised Host; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome; Voriconazole | 2015 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Voriconazole combined with low-dose amphotericin B liposome for treatment of cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Humans; Male; Meningitis, Cryptococcal; Voriconazole | 2016 |
Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient.
Topics: Adrenal Cortex Hormones; Anti-Retroviral Agents; Antifungal Agents; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Immune System; Inflammation; Liver Transplantation; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2008 |
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2009 |
Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Male; Meningitis, Cryptococcal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
Topics: Adult; Antifungal Agents; Cryptococcus neoformans; Drug Interactions; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Meningitis, Cryptococcal; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2010 |
[Cryptococcal meningitis with a fatal outcome in an immunocompetent adult].
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Headache; Hearing Loss, Bilateral; Humans; Immunocompetence; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Spinal Puncture; Triazoles; Voriconazole | 2010 |
Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir.
Topics: Anti-HIV Agents; Antifungal Agents; Cerebrospinal Fluid; Dideoxynucleosides; Drug Monitoring; HIV Infections; Humans; Interferon-gamma; Lamivudine; Male; Meningitis, Cryptococcal; Pyrimidines; Ritonavir; Serum; Triazoles; Voriconazole; Young Adult | 2010 |
[Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].
Topics: Administration, Oral; Aged, 80 and over; Amphotericin B; Antigens, Fungal; Cerebrospinal Fluid; Cryptococcus neoformans; Drug Therapy, Combination; Female; Humans; Liposomes; Meningitis, Cryptococcal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Voriconazole: may be an option for treatment of cryptococcal meningitis.
Topics: Animals; Antifungal Agents; Humans; Infant, Newborn; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2011 |
Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Injections, Spinal; Male; Meningitis, Cryptococcal; Mice; Pyrimidines; Triazoles; Voriconazole | 2012 |
Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Microbial Sensitivity Tests; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Intraventricular cryptococcoma successfully treated with liposomal amphotericin B and voriconazole: a case report].
Topics: Amphotericin B; Humans; Liposomes; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole | 2012 |
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; HIV Infections; Humans; Interferon-gamma; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Two rare cases of central nervous system opportunistic mycoses.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus nidulans; Cryptococcus neoformans; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Neuroaspergillosis; Opportunistic Infections; Pregnancy; Pregnancy Complications, Infectious; Rare Diseases; Treatment Outcome; Voriconazole | 2012 |
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.
Topics: Antifungal Agents; Brain Abscess; Chronic Disease; Cryptococcus neoformans; Fluconazole; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Renal Insufficiency; Time Factors; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Voriconazole in an infant with cryptococcal meningitis.
Topics: Antifungal Agents; Humans; Infant; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole | 2008 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |